YalePharma developed proprietary, patented platforms for specific clients and partners, including the following:

 

Oral	Inhalation
Transdermal	Parenteral
Implants	Nasal
Topical	Transmucosal
Mucosal	Needle-Free
Modified-Release	Solid Dosage
Controlled-Release	Sustained-Release
Fast-Dissolving	Metered Dose
Capsules	Time-Released
Site-Specific	Aerosols
Lyophilization	Genetic Delivery Systems
Polymers And Biomaterials	Biodegradable
Vaccines	Protein And Peptide
Ophthalmologic	Rectal
Vaginal	Colon
Drug Targeting	Liposome
Gene Therapy	Lipids
Nano Scaled Delivery	Nanomed
Other:

YalePharma Advanced Drug Delivery (YalePharma ADD) Staffs